In a context where health innovation requires significant investment from its earliest stages, identifying the right funding levers is a strategic challenge for every project leader. Amidst regulatory requirements, lengthy development cycles, and technological competition, access to appropriate funding can make all the difference in the success of a startup or an R&D project.
In this context, Eurobiomed, in partnership with Bpifrance and with the support of F.Initiatives, is organizing a breakfast meeting dedicated to non-dilutive funding. This event aims to provide concrete and operational insights into all available mechanisms to accelerate your health innovations.
We will address the main aids and opportunities: initial support mechanisms for startup creation, CIR, CII, JEI status, as well as regional, national, and European calls for projects. The objective: to enable you to identify the most relevant mechanisms based on your project's maturity and needs.
This event will also be a privileged moment for exchanges with ecosystem experts, in a convivial format conducive to questions, experience sharing, and professional networking.
This networking morning is reserved for members, partners, and innovative companies.
Programme:
- 8:30 AM: Participant Welcome
- 9h: Mot de bienvenue; Emmanuel Le Bouder, Eurobiomed
- 9h05: Panorama des premières aides régionales Bpifrance; Arthur Sagrandi, Bpifrance
- 9h25: Les dispositifs de soutien à la R&D (CIR, CII, JEI); Clémence Demarez, F.Initiatives
- 9h45: Les aides directes au national; Emmanuel Le Bouder, Eurobiomed
- 10h05: Retour d’expérience d’une entreprise lauréaté; Pierre Berthet-Rayne, Caranx Medical
